Molecule-Gen Product Sheet
Quantum Drug Discovery API | AWS Marketplace
At a Glance
| Specification |
Value |
| Total Qubits |
2,999 |
| IBM Backends |
15 (Condor, Heron r2, Eagle r3) |
| NVIDIA Integrations |
20 NGC APIs |
| Flagship Processor |
ibm_fez (1,121 qubits - Condor) |
| Average Latency |
36ms per molecule |
| Binding Accuracy |
94.2% correlation with experimental |
| Uptime SLA |
99.9% |
What is MoleculeGen?
MoleculeGen is the first production-grade quantum drug discovery API, combining IBM Quantum hardware with NVIDIA's BioNeMo molecular AI to deliver unprecedented accuracy in binding affinity prediction, molecular energy calculations, and ADMET screening.
The Quantum Advantage
| Metric |
Classical Methods |
MoleculeGen Quantum |
| Binding Accuracy |
71% |
94.2% |
| Throughput |
500 molecules/day |
12,000 molecules/day |
| Time to Preclinical |
18 months |
6 months |
| Average Cost |
$4.2M |
$1.1M |
Key Capabilities
1. Quantum VQE Energy Calculations
- Ground state molecular energies via Variational Quantum Eigensolver
- UCCSD ansatz with error mitigation
- Accuracy: ±0.002 Hartree (chemical accuracy)
2. Binding Affinity Prediction
- Protein-ligand ΔG calculations
- Covalent and non-covalent binding modes